ropinirole has been researched along with digoxin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Beerahee, A; Citerone, D; Davy, M; Fitzpatrick, K; Lopez-Gil, A; Stocchi, F; Taylor, A | 1 |
1 review(s) available for ropinirole and digoxin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for ropinirole and digoxin
| Article | Year |
|---|---|
The effect of steady-state ropinirole on plasma concentrations of digoxin in patients with Parkinson's disease.
Topics: Aged; Anti-Arrhythmia Agents; Antiparkinson Agents; Digoxin; Drug Administration Schedule; Drug Interactions; Humans; Indoles; Parkinson Disease; Placebos; Single-Blind Method | 1999 |
1 other study(ies) available for ropinirole and digoxin
| Article | Year |
|---|---|
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |